Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Robichaud AL"'
Publikováno v:
In Value in Health June 2024 27(6) Supplement:S191-S191
Autor:
Guenther LM, Dharia NV, Ross L, Saur Conway A, Robichaud AL, Catlett JL, Wechsler C, Frank ES, Goodale AB, Church AJ, Tseng YY, Guha R, McKnight C, Janeway KA, Boehm JS, Mora J, Davis MI, Alexe G, Piccioni F, Stegmaier K
Publikováno v:
CLINICAL CANCER RESEARCH
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
PURPOSE: Novel targeted therapeutics have transformed the care of subsets of patients with cancer. In pediatric malignancies, however, with simple tumor genomes and infrequent targetable mutations, there have been few new FDA-approved targeted drugs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0e89c0c7bf876fd4c61c36ffab070477
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=15250
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=15250
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Comery, Thomas A., Aschmies, Suzan, Haydar, Simon, Hughes, Zoe, Huselton, Christine, Kowal, Dianne, Kramer, Angela, McFarlane, Geraldine, Monaghan, Michael, Smith, Deborah, Zhang, Guoming, Zhang, Jean, Zhang, Mei-Yi, Reinhart, Peter, Robichaud, Al J., Pangalos, Menelas N.
Publikováno v:
In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2010 6(4) Supplement:S548-S549
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Paolino J; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts., Dimitrov B; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Apsel Winger B; Department of Pediatrics, Division of Hematology/Oncology, Benioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Sandoval-Perez A; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Rangarajan AV; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Ocasio-Martinez N; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tsai HK; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Li Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Robichaud AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Khalid D; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Hatton C; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gillani R; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts., Polonen P; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee., Dilig A; Integrated Oncology, Shelton, Connecticut., Gotti G; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Kavanagh J; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Adhav AA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gow S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tsai J; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Li Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Bledsoe J; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Kim AS; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Tasian SK; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, and Department of Pediatrics and Abramson Cancer Center at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Cooper SL; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland., Cooper TM; Seattle Children's Hospital, Cancer and Blood Disorders Center, Seattle, Washington., Hijiya N; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Irving Medical Center, New York, New York., Sulis ML; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Shukla NN; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Magee JA; Division of Pediatric Hematology/Oncology, Washington University/St. Louis Children's Hospital, St. Louis, Missouri., Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee., Burke MJ; Medical College of Wisconsin, Children's Hospital of Wisconsin, Milwaukee, Wisconsin., Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mar BG; Blueprint Medicines, Cambridge, Massachusetts., Jacobson MP; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Harris MH; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts., Place AE; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts., Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Nov 14; Vol. 29 (22), pp. 4613-4626.
Autor:
Mabe NW; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Huang M; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA., Dalton GN; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA., Alexe G; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Schaefer DA; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA., Geraghty AC; Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA., Robichaud AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA., Conway AS; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA., Khalid D; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA., Mader MM; Institute for Stem Cell Biology and Regenerative Medicine, Stanford, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Belk JA; Department of Computer Science, Stanford University School of Medicine, Stanford, CA, USA., Ross KN; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Sheffer M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Linde MH; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA.; Immunology Graduate Program, Stanford University School of Medicine, Stanford, CA, USA., Ly N; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Yao W; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Rotiroti MC; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA., Smith BAH; Department of Chemical & Systems Biology, Stanford University School of Medicine, Stanford, CA, USA., Wernig M; Institute for Stem Cell Biology and Regenerative Medicine, Stanford, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Bertozzi CR; Department of Chemistry, Stanford University School of Medicine, Stanford, CA, USA.; Howard Hughes Medical Institute, Stanford University, Stanford, CA, USA., Monje M; Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.; Howard Hughes Medical Institute, Stanford University, Stanford, CA, USA., Mitsiades CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Majeti R; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA., Satpathy AT; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA. Kimberly_stegmaier@dfci.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Kimberly_stegmaier@dfci.harvard.edu., Majzner RG; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA. rmajzner@stanford.edu.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. rmajzner@stanford.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. rmajzner@stanford.edu.
Publikováno v:
Nature cancer [Nat Cancer] 2022 Aug; Vol. 3 (8), pp. 976-993. Date of Electronic Publication: 2022 Jul 11.
Autor:
Ellegast JM; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Alexe G; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Bioinformatics Graduate Program, Boston University, Boston, Massachusetts., Hamze A; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Lin S; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Uckelmann HJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Rauch PJ; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Pimkin M; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Ross LS; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Dharia NV; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Robichaud AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Conway AS; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Khalid D; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Perry JA; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Wunderlich M; Division of Experimental Hematology and Cancer Biology, Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Benajiba L; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.; Université de Paris, INSERM U944 and CNRS 7212, Institut de Recherche Saint Louis, Hôpital Saint Louis, APHP, Paris, France., Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Nabet B; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington., Gray NS; Department of Chemical and Systems Biology, Chem-H and Stanford Cancer Institute, Stanford Medicine, Stanford University, Stanford, California., Orkin SH; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2022 Jul 06; Vol. 12 (7), pp. 1760-1781.
Autor:
Durbin AD; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Division of Molecular Oncology, Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Wang T; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wimalasena VK; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Zimmerman MW; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Li D; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Dharia NV; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Mariani L; Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Shendy NAM; Division of Molecular Oncology, Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Nance S; Division of Molecular Oncology, Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Patel AG; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Shao Y; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee., Mundada M; Division of Molecular Oncology, Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee., Maxham L; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee., Park PMC; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Sigua LH; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Morita K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Conway AS; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Robichaud AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Perez-Atayde AR; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Bikowitz MJ; Drug Discovery Department, Moffit Cancer Center, Tampa, Florida.; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida., Quinn TR; Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana., Wiest O; Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana., Easton J; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee., Schönbrunn E; Drug Discovery Department, Moffit Cancer Center, Tampa, Florida.; Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida., Bulyk ML; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Abraham BJ; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Look AT; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts., Qi J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2022 Mar 01; Vol. 12 (3), pp. 730-751.
Autor:
Lin S; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Larrue C; Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Scheidegger NK; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Seong BKA; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Dharia NV; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Kuljanin M; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Wechsler CS; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts., Kugener G; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Robichaud AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts., Conway AS; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts., Mashaka T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mouche S; Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Adane B; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Ryan JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mancias JD; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Younger ST; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Piccioni F; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Lee LH; Division of Oncology, Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio., Wunderlich M; Division of Experimental Hematology and Cancer Biology, Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Letai A; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tamburini J; Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, Massachusetts. Kimberly_stegmaier@dfci.harvard.edu.; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2022 Feb; Vol. 12 (2), pp. 432-449. Date of Electronic Publication: 2021 Sep 16.